Geographic variation in systemic treatment of metastatic pancreatic adenocarcinoma (mPAC) patients in real world across Europe Julien Taieb, et al., O-002
Gemcitabine with nab-paclitaxel in patients with locally advanced or metastatic pancreatic ductal adenocarcinoma (PDAC): a quality of life randomized cross-over study (QOLINPAC) Gabriela Chiritescu, et al., O-003
Selected subgroup analyses of liposomal irinotecan (nal-IRI) in patients with metastatic pancreatic ductal adenocarcinoma (Mpdac) in the global NAPOLI-1 phase III trial Teresa Macarulla Mercadé. et al., O-004
